Abstract:Objective To provide direct interventions for patients with chronic obstructive pulmonary disease(COPD)and relevant bases of medical decision-making and resource allocation for the government by investigation of those biology-psychology-social factors which influence COPD patients medical behaviors. Methods COPD patients were followed in July in 2014 with general conditions, severity grading and questionnaire of quality of life(QOL). Telephoned patients every month, processed the health education every six months and recorded their attendance times and their compliance status. The study ended in December 2015.The final QOL questionnaire investigation was proceeded and those objects were divided into different groups according their outcomes: aggravating group, illness group without change, improved group. Multinomial Logistic regression were used to find those biologicalpsychological-social factors that influenced these COPD patients' diagnosis and outcome. Variance analysis were used in groups or between-group to find out the relationship between prognosis and QOL. Results Patients with reimbursement proportion 70％ higher, better compliance with health education, no complications, illness lighter(A/B)in the beginning would get better than the others(OR: 10.35 vs2.147 vs 5.791 vs 1.51, P＜0.05). Scores of aggravating group patients in the physiological, psychological and environmental area of QOL were significantly lower at the end of the study than that in the beginning of study(P＜0.05). Scores in psychological area of illness group without change were obviously higher at the end of the study than that in the beginning of study(P＜0.05). Scores in physiological area of improved group were obviously higher at the end of the study than that in the beginning of study(P＜0.05). In the beginning of the study the QOL scores in all area of improved group patients were obviously higher than that of aggravating group patients(P＜0.05).Scores in social relationship and environmental area of illness group without change patients were obviously higher than that of aggravating group patients(P＜0.05).At the end of the study the QOL scores in all area of both improved or illness group without change patients were obviously higher than that of aggravating group patients(P＜0.05). Conclusions Reimbursement proportion 70％ or higher, better compliance, no complications, illness lighter(A/B)are protective factors. Underweight or normal, frequent acute attack and lower compliance are risk factors of COPD. Patients with higher QOL scores got improved or stable conditions. The QOL scores in both illness group without change or improved group patients are higher than that in aggravating group patients.

The Observation of Rosuvastatin Affect on IL-8 and the Quality of Life on COPD Patients

Effects of Different Doses of Rosuvastatin on High-sensitivity C-reactive Protein(hs-CRP) and Interleukin-6 (IL-6) in Patients with Acute Coronary Syndrome.

Therapeutic effect of ipratropium bromide combined with long-term domiciliary oxygen therapy for patients with chronic obstructive pulmonary disease

Clinical Study for Dose-Effect and Safety of Rosuvastatin in Patients with Primary Hypercholesterolemia

Effect of Bi-level Positive Airway Pressure Ventilation Combined with Seretide on Quality of Life of Elder Patients with Moderate and Severe Chronic Obstructive Pulmonary Disease and Type Ⅱ Respiratory Failure

A 12‐month Follow‐up Study on the Preventive Effect of Oral Lansoprazole on Acute Exacerbation of Chronic Obstructive Pulmonary Disease

To Observe the Effects of Low Dose Erythromycin and Salmeterol/fluticasone Propionate for Patients with Chronic Obstructive Pulmonary Disease in Stable Phase

The effect of statin on concentrations of serum CRP,IL-8 and pulmonary function in patients with acute exacerbations of chronic obstructive airway disease

Comparison of efficacy of rosuvastatin and artovastatin in treatment of hypercholesterolemia

Effectiveness of Long-Term Using Statins in COPD – a Network Meta-Analysis

Effect of regular drug administration in patients with stable COPD

Effect of Vitamin A on the Cytokines Expression of COPD Patients in Stable Stage

Effects of Statins on Patients with Chronic Obstructive Pulmonary Disease:A Meta Analysis

Changes of Metailoproteinase-9, Tissue Inhibitor of Metalloproteinase-1 and Interleukin-8 in Elderly Patients with Chronic Obstructive Pulmonary Disease and the Effects of Different Drugs

Study on the intervention effect of continued nursing on the quality of life of patients with chronic obstructive pulmonary disease

Study of Effects of Seretide on Inflammatory Factors, Pulmonary Function and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease

Observation of curative effect of long-term family oxygen ( LTOT) and pulmonary rehabilitation on COPD patients complicated with chronic respiratory failure

Effect of inhalation drug therapy on inflammatory factors and quality of life on stable chronic obstructive pulmonary disease

The effect of long-term domicilinary axygen therapy on the patients' condition of chronic obstructive pulmonary disease during the acute exacerbation period

Correlation Study of Chronic Obstructive Pulmonary Disease Patients Outcomes and Quality of Life

Effect of aspirin and statins on pulmonary function and inflammation in patients with AECOPD